Inspire Investing, LLC Dexcom Inc Transaction History

Inspire Investing, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $238,236 - $465,646	3,504 Added 467.82%	4,253 $317,000
Q1 2022 Apr 21, 2022	SELL	$94.08 - $130.2 $107,063 - $148,167	-1,138 Reduced 60.31%	749 $383,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $178,051 - $223,226	1,371 Added 265.7%	1,887 $1.01 Million
Q4 2021 Feb 03, 2022	SELL	$129.87 - $162.82 $156,233 - $195,872	-1,203 Reduced 69.98%	516 $277,000
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $183,434 - $246,126	1,719 New	1,719 $940,000
Q1 2021 Apr 30, 2021	SELL	$84.79 - $104.74 $83,094 - $102,645	-980 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $76,440 - $102,410	980 New	980 $362,000
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $2,068 - $3,476	-33 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$47.79 - $75.63 $1,577 - $2,495	33 New	33 $9,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.